Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Proteins & Peptides
Filter     Order     Display # 
Date Item Title
24 Jan 2008 Nuvelo Announces Results from Phase 3 NAPA Program in Acute Peripheral Arterial Occlusion
24 Jan 2008 Takeda Doses First Patient in A U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
23 Jan 2008 Human Genome Sciences Modifies Dosing In Achieve Trials of Albuferon(R)
23 Jan 2008 DIREVO to collaborate with MedImmune on therapeutic protease for the treatment of CNS diseases
23 Jan 2008 Bayer HealthCare Pharmaceuticals (BAY) Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
22 Jan 2008 Tercica initiates phase II clinical trial with next-generation growth hormone product for the treatment of short stature
22 Jan 2008 Ambrilia Reports Positive Phase III Preliminary Results Showing the Safety and Efficacy of its Prolonged-Release Formulation of Octreotide
22 Jan 2008 Oramed Pharmaceuticals Commences Phase 1B Clinical Trials
22 Jan 2008 Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology
22 Jan 2008 ImaRx and Microbix sign Letter of Intent to manufacture and further develop the FDA-approved clot-dissolving drug, Abbokinase(R)
22 Jan 2008 Protalix Biotherapeutics Extends Research Agreement With Yissum Ltd. Based on Promising Acetylcholinesterase Program Results in Animal Study
17 Jan 2008 Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
17 Jan 2008 FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical
17 Jan 2008 Adherex Announces Phase IIb Expansion of ADH-1 Combination Study in Melanoma
16 Jan 2008 Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
15 Jan 2008 Protox Initiates Phase 2 Prostate Cancer Study
15 Jan 2008 Alfacell Corporation Licenses ONCONASE(R) U.S. Commercial Rights to Strativa Pharmaceuticals
15 Jan 2008 Kamada Announces Successful Completion of Phase I Studies with Aerosolized AAT for the Treatment of Lung Diseases
15 Jan 2008 Molecular Partners AG collaborates with Centocor Research & Development, Inc.
14 Jan 2008 Schering-Plough Reports Top-Line Results of the IDEAL Study
14 Jan 2008 Novo Nordisk refocuses its activities within inhaled insulin and discontinues the development of AERx(R)
14 Jan 2008 ARTES and Minapharm sign long-term strategic development agreement
14 Jan 2008 King Pharmaceuticals Reports FDA Approval Of Revised Labeling Regarding Purity Of THROMBIN-JMI(R)
14 Jan 2008 Three Rivers PharmaceuticalsŪ, LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
13 Jan 2008 New published data show otoprotective effect of AM-111 in case of inner ear inflammatory responses (acute labyrinthitis)
11 Jan 2008 Jerini Announces Collaboration Agreement with Baxter to Develop Novel Peptide for Use in Therapeutic Protein Purification
11 Jan 2008 LFB Biotechnologies to Collaborate With GTC Biotherapeutics on Coagulation Factor IX Program
10 Jan 2008 Allon trial studies pharmacokinetics of AL-108 & AL-208
10 Jan 2008 OMRIX Biopharmaceuticals Receives FDA Approval for General Hemostasis in Surgery Indication for EVICEL(TM) Liquid Fibrin Sealant (Human)
09 Jan 2008 ZymoGenetics Begins Phase 2 Trial in Renal Cell Cancer Evaluating IL-21 Combined with Nexavar(R)
08 Jan 2008 Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
08 Jan 2008 Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure
08 Jan 2008 Chemokine Therapeutics Receives Approval From FDA to Commence Phase II Study
07 Jan 2008 Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
07 Jan 2008 Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
07 Jan 2008 Catalyst Biosciences and Centocor Research & Development, inc. fForm collaboration to discover and develop engineered protease therapeutics
07 Jan 2008 Baxter Announces Recombinant Factor IX Development Program for Hemophilia B
03 Jan 2008 Protox announces positive final results from BPH study
21 Dec 2007 Lundbeck expands agreement with PAION for desmoteplase
21 Dec 2007 Pfizer Receives Approvable Letter from FDA for Dalbavancin
21 Dec 2007 Pharming Submits Request For Re-examination Of CHMP Opinion For European Marketing Authorization Application For Rhucin(R)
21 Dec 2007 Jerini Receives NDA Filing Acceptance and Priority Review from the FDA for Icatibant in the Treatment of HAE
21 Dec 2007 ImaRx Therapeutics Submits Urokinase Data to FDA Supporting Extended Expiration Dating
20 Dec 2007 Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
20 Dec 2007 Altor BioScience Advances Clinical Trial for Targeted Cancer Therapeutic, ALT-801
19 Dec 2007 BioLineRx Announces Presentation of Pre-Clinical Data Demonstrating that BL-2030 Reduces Tumor Growth and Prevents Metastasis in Model of Prostate Cancer
19 Dec 2007 Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights
18 Dec 2007 ZymoGenetics Begins Phase 2 Clinical Trial of IL-21 in Melanoma
18 Dec 2007 Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
17 Dec 2007 Novo Nordisk licenses global rights to potential new haemostasis therapy
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 251 - 300 of 1301

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics